References
- GreenwoodDLincosaminesFinchRGGreenwoodDNorrbySRWhitleyRJAntibiotic and Chemotherapy: Anti-infective Agents and Their Use in TherapyEdinburghSaunders Elsevier2010272275
- Lincocin® [product information]. Australian Government Department of HealthTherapeutics Goods Administration Available from: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05409-3&d=2016020516114622412Accessed February 5, 2016
- Monthly Index of Medical Specialities (eMIMS)Lincocin2015 Available from: https://www.mimsonline.com.au.dbgw.lis.curtin.edu.au/Search/Search.aspxAccessed December 2, 2015
- Australian Government Department of HealthSchedule of Pharmaceutical Benefits: Effective 1 June–30 June 2015CanberraCommonwealth of Australia2015 Available from: http://www.pbs.gov.au/publication/schedule/2015/06/2015-06-01-general-schedule.pdfAccessed December 2, 2015
- American Society of Health-System PharmacistsHandbook on Injectable Drugs18th edBethesda (MD)ASHP2014
- ForistAABrownLWRoyerMEAcid stability of lincomycinJ Pharm Sci196554347647714301594
- WalkerSEIazzettaJLawSBinieckiKStability of commonly used antibiotic solutions in an elastomeric infusion deviceCan J Hosp Pharm201063321222422478981
- CatenaEPerezGSadabaBAzanzaJRCampaneroMAA fast reverse-phase high performance liquid chromatographic tandem mass spectrometry assay for the quantification of clindamycin in plasma and saliva using a rapid resolution packageJ Pharm Biomed Anal200950464965419269123
- Medicines and Healthcare Products Regulatory AgencyBritish Pharmacopoeia2014LondonStationery Office2013
- US Pharmacopeial ConventionUS Pharmacopeia National Formulary (USP37-NF32)Rockville (MD)US Pharmacopeia National Formulary2014
- HerrRRSlompGLincomycin. II. Characterization and gross structureJ Am Chem Soc19678910244424476042748